Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 154th in Top Companies
- 22nd in Health
- 20th in Pharma
By Employees
(400)- 414th in Top Companies
- 65th in Health
- 42nd in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- 3:16pm US retailers hit by ‘worst year since 2008’ for discounting
- 1:39pm Creed wants UK fishery access in return for giving UK financial firms easy EU access
- 1:39pm Creed wants UK fishery access in UK financial passporting deal
- Dec 14
- Dec 13 Operating profits at INEC owner decrease 7% to €1.32m